Press Releases
In recognition of Macular Degeneration Awareness Month this February, BrightFocus Foundation, a nonprofit dedicated to ending diseases of mind and sight, is offering a variety of free educational resources to help individuals with macular degeneration and their loved ones navigate the disease.
January is National Glaucoma Awareness Month, and BrightFocus Foundation is offering a variety of free educational resources to help individuals with glaucoma and their loved ones navigate the disease.
Global brain and vision research nonprofit BrightFocus Foundation has appointed digital health executive, entrepreneur, and speaker Paul A. Campbell as a new member of its board of directors.
More than 75 graduate students, postdoctoral fellows, and other early-career scientists from around the world participated in this year’s BrightFocus Alzheimer’s Fast Track, Nov. 9-11, 2022, in San Diego.
BrightFocus Foundation’s 2022 annual report highlights an incredible year of pioneering neurodegenerative research.
BrightFocus Foundation yesterday presented its first-ever Alzheimer’s Disease Research (ADR) named awards to two leading researchers in recognition of their innovative work to prevent, treat, and, ultimately, cure Alzheimer’s disease.
The newly expanded accessible audio program will connect patients with vision experts and provide the latest glaucoma research news.
Findings are the first to show a statistically significant decrease in cognitive decline by an anti-amyloid drug.
The impact factor of Molecular Neurodegeneration, the official scientific journal of BrightFocus Foundation, has risen to 18.879, according to its publisher, up from 14.195 a year ago.
BrightFocus Foundation’s Alzheimer’s Disease Research program announced a request for scientific proposals for promising research on Alzheimer’s disease and related dementias. The application deadline is November 1, 2022, for projects beginning in 2023.
